OPEN END TURBO LONG - HALEON Share Price

Certificat

DE000MD8R280

Real-time Bid/Ask 01:45:12 23/05/2024 pm IST
0.46 EUR / 0.47 EUR +8.14% Intraday chart for OPEN END TURBO LONG - HALEON
Current month-20.37%
1 month-14.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
22/24/22 0.43 -4.44%
21/24/21 0.45 -8.16%
20/24/20 0.49 +11.36%
17/24/17 0.44 0.00%
16/24/16 0.44 -4.35%

Delayed Quote Börse Stuttgart

Last update May 22, 2024 at 03:15 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MD8R28
ISINDE000MD8R280
Date issued 29/09/2022
Strike 293.1 p
Maturity Unlimited
Parity 1 : 1
Emission price 0.2
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.98
Lowest since issue 0.031
Spread 0.01
Spread %2.13%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.311 GBP
Average target price
3.62 GBP
Spread / Average Target
+9.33%
Consensus